Arquivos de Neuro-Psiquiatria · 2014 · 35 citations · 21 references
DentistryOral MedicineOrofacial PainPain MedicineSalivary DiagnosticsBurning Mouth SyndromeOral ConditionsOral Mucosal PainXerostomia ManagementBurning Mouth SymptomsClinical Xerostomia Severity ScalesManagement Of Medication-induced XerostomiaOral Burning SymptomsPharmacologic Treatment Of XerostomiaTopical Anti-inflammatory PreparationsTopical Medication AdministrationXerostomia Severity Assessment
OBJECTIVE: To assess the efficacy of anti-xerostomic topical medication (urea 10%) in patients with burning mouth syndrome (BMS). METHOD: Thirty-eight subjects diagnosed with BMS according to the International Association for the Study of Pain guidelines were randomized to either placebo (5% sodium carboxymethylcellulose, 0.15% methyl paraben, and 10% glycerol in distilled water qsp 100 g) or treatment (urea 10%) to be applied to the oral cavity 3-4 times per day for 3 months. The patients were evaluated before and after treatment with the following instruments: the EDOF-HC protocol (Orofacial Pain Clinic - Hospital das Clínicas), a xerostomia questionnaire, and quantitative sensory testing. RESULTS: There were no differences in salivary flow or gustative, olfactory, or sensory thresholds (P>0.05). Fifteen (60%) patients reported improvement with the treatments (P=0.336). CONCLUSION: In conclusion, there were no differences between groups, and both exhibited an association between reported improvement and salivation.
21
Classification of chronic pain
Harold Merskey · Medical Entomology and Zoology · 1994 · 2.8K citations
Dental Abstracts · 2014 · 255 citations
Miriam Grushka, Barry J. Sessle · Dental Clinics of North America · 1991 · 204 citations
Testing olfaction in a clinical setting.